Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
Serafini P, Borrello I, Bronte V. Serafini P, et al. Among authors: borrello i. Semin Cancer Biol. 2006 Feb;16(1):53-65. doi: 10.1016/j.semcancer.2005.07.005. Epub 2005 Sep 15. Semin Cancer Biol. 2006. PMID: 16168663 Review.
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.
Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H. Staveley-O'Carroll K, et al. Among authors: borrello i. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1178-83. doi: 10.1073/pnas.95.3.1178. Proc Natl Acad Sci U S A. 1998. PMID: 9448305 Free PMC article.
Tolerance and cancer: a critical issue in tumor immunology.
Sotomayor EM, Borrello I, Levitsky HI. Sotomayor EM, et al. Among authors: borrello i. Crit Rev Oncog. 1996;7(5-6):433-56. doi: 10.1615/critrevoncog.v7.i5-6.30. Crit Rev Oncog. 1996. PMID: 9467666 Review.
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
Sotomayor EM, Borrello I, Tubb E, Rattis FM, Bien H, Lu Z, Fein S, Schoenberger S, Levitsky HI. Sotomayor EM, et al. Among authors: borrello i. Nat Med. 1999 Jul;5(7):780-7. doi: 10.1038/10503. Nat Med. 1999. PMID: 10395323
A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines.
Borrello I, Sotomayor EM, Cooke S, Levitsky HI. Borrello I, et al. Hum Gene Ther. 1999 Aug 10;10(12):1983-91. doi: 10.1089/10430349950017347. Hum Gene Ther. 1999. PMID: 10466632
In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.
Sotomayor EM, Borrello I, Tubb E, Allison JP, Levitsky HI. Sotomayor EM, et al. Among authors: borrello i. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11476-81. doi: 10.1073/pnas.96.20.11476. Proc Natl Acad Sci U S A. 1999. PMID: 10500201 Free PMC article.
Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines.
Borrello I, Sotomayor EM, Rattis FM, Cooke SK, Gu L, Levitsky HI. Borrello I, et al. Blood. 2000 May 15;95(10):3011-9. Blood. 2000. PMID: 10807763
New approaches to treating malignances with stem cell transplantation.
Margolis J, Borrello I, Flinn IW. Margolis J, et al. Among authors: borrello i. Semin Oncol. 2000 Oct;27(5):524-30. Semin Oncol. 2000. PMID: 11049020 Review.
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.
Sotomayor EM, Borrello I, Rattis FM, Cuenca AG, Abrams J, Staveley-O'Carroll K, Levitsky HI. Sotomayor EM, et al. Among authors: borrello i. Blood. 2001 Aug 15;98(4):1070-7. doi: 10.1182/blood.v98.4.1070. Blood. 2001. PMID: 11493453
New Developments in the Therapy of Acute Myelocytic Leukemia.
Gorin NC, Estey E, Jones RJ, Levitsky HI, Borrello I, Slavin S. Gorin NC, et al. Among authors: borrello i. Hematology Am Soc Hematol Educ Program. 2000:69-89. doi: 10.1182/asheducation-2000.1.69. Hematology Am Soc Hematol Educ Program. 2000. PMID: 11701536
This review examines the search for new agents and new modes of therapy. In Section I, Dr. Estey discusses new agents directed at various targets, such as CD33, angiogenesis, inappropriately methylated (suppressor) genes, cell cycle checkpoints, proteosomes, multidrug resi …
This review examines the search for new agents and new modes of therapy. In Section I, Dr. Estey discusses new agents directed at var …
111 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback